Evidence map›Paper›PMID 42323302›Full record

ArticleNature communications2026

Trigger-day hCG effects on DNA methylation and neurodevelopment in ART offspring.

Yue Jiang, Xiaoyu Wei, Xianghu Liu, Jun Zhou, Muyi Han, Anqi Zhao, Hong Lv, Yangqian Jiang, Yayun Gu, Cheng Wang and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Yue Jiang *State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.
Xiaoyu Wei *State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.
Xianghu Liu *State Key Laboratory of Reproductive Medicine, Department of Clinic Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, China.
Jun ZhouState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.
Muyi HanState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.
Anqi ZhaoState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.
Hong LvState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0002-6624-1742
Yangqian JiangState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.
Yayun GuState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.
Cheng WangState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0002-8193-9276
Juncheng DaiState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0002-3909-5671
Hongxia MaState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0002-9821-6955
Guangfu JinState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0003-0249-5337
Ran HuoState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0001-5166-127X
Qiang WangState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.
Xuejiang GuoState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0002-0475-5705
Hongbing ShenState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0002-2581-5906
Yuan LinState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China. yuanlin@njmu.edu.cn.ORCID http://orcid.org/0000-0001-8961-8971
Yuanlin HeState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China. yuanlinhe@njmu.edu.cn.
Qigang ZhouState Key Laboratory of Reproductive Medicine, Department of Clinic Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, China. qigangzhou@njmu.edu.cn.ORCID http://orcid.org/0000-0003-3870-3070
Zhibin HuState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China. zhibin_hu@njmu.edu.cn.ORCID http://orcid.org/0000-0002-8277-5234

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82221005National Natural Science Foundation of China (National Science Foundation of China) 82495190National Natural Science Foundation of China (National Science Foundation of China) U24A20664
6 · The paper itself

Abstract

Assisted reproductive technology influences the epigenetic landscape of offspring, but whether trigger-day pharmacotherapy affects epigenetics and neurodevelopment remains unclear. In a prospective birth cohort of 365 families, higher trigger-day human chorionic gonadotropin dose associates with reduced global DNA methylation in peripheral blood from offspring conceived assisted reproduction compared with naturally conceived children. In a cohort of 1333 singleton offspring, higher maternal human chorionic gonadotropin dose associates with increased risk of suboptimal neurodevelopment. In mice, transient human chorionic gonadotropin exposure impairs offspring neurocognitive behaviours, reduces hippocampal dorsal dentate gyrus neurogenesis, and downregulates euchromatic histone methyltransferase 1 expression with reduced methylation observed in oocytes. Microinjection of euchromatic histone lysine methyltransferase 1 mRNA into exposed zygotes restores neurogenesis and improves behavioural outcomes in offspring. These findings suggest potential epigenetic and neurodevelopmental risks of higher-dose human chorionic gonadotropin exposure and support optimized trigger protocols in assisted reproductive technology that balance treatment efficacy with long-term offspring health.

Indexed as

Chorionic GonadotropinDNA MethylationReproductive Techniques, AssistedAnimalsEpigenesis, GeneticFemaleHistone-Lysine N-MethyltransferaseHumansMaleMiceNeurodevelopmentNeurogenesisPregnancyPrenatal Exposure Delayed EffectsProspective StudiesChorionic GonadotropinHistone-Lysine N-Methyltransferase

Identifiers

PMID42323302
PMCPMC13438690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.